Press Releases
🇺🇸 FDA Page 8FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Access critical pharma & biotech press releases. Stay ahead on drug approvals, clinical trials, M&A, and regulatory updates impacting global markets.
Showing 85–96 of 212 articles
AbbVie Submits FDA Application for Upadacitinib (RINVOQ) to Treat Severe Alopecia Areata
Wave Life Sciences WVE-007 Phase 2a Trial Gets FDA Approval for Obesity and Type 2 Diabetes Treatment
Cellenkos Receives FDA Clearance for CK0801 Phase 2 Trial in Aplastic Anemia
AstraZeneca's SAPHNELO Autoinjector Approved by FDA for Self-Administration in Lupus Treatment
DMX-200 ACTION3 Trial Maintains Statistical Power Above 90% Following Blinded Data Review
Concept Medical Presents 3-Year SIRONA Trial Data at Charing Cross Symposium 2026
Intellia Therapeutics Submits FDA Application for Lonvo-Z, First CRISPR Gene Therapy for Hereditary Angioedema
Intellia Therapeutics Achieves First-Ever Positive Phase 3 Results for In Vivo Gene Editing with Lonvoguran Ziclumeran in Hereditary Angioedema
Sagimet Biosciences Plans Phase 3 Denifanstat Trial for Acne Treatment in 2026
Apollomics Advances Vebreltinib c-MET Inhibitor with Phase 2/3 IND Submission for NSCLC Treatment
Aclaris Therapeutics ATI-052 Phase 1a Trial Results and ATI-2138 Lead Indication Update Set for April 28, 2026
OSE Immunotherapeutics' Pegrizeprument (VEL-101) Receives FDA Orphan Drug Designation for Heart Transplant Rejection Prevention